Format

Send to

Choose Destination
See comment in PubMed Commons below
Diabetes Obes Metab. 2009 Nov;11(11):997-1000. doi: 10.1111/j.1463-1326.2009.01068.x. Epub 2009 Jun 16.

Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.

Author information

  • 1Department of Diabetes and Endocrinology, University Hospital South Manchester NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, UK. naveedy@tinyonline.co.uk

Abstract

The benefits of aspirin therapy in reducing the subsequent risk of myocardial infarction, stroke and death is well documented in individuals with cardiovascular disease including those with diabetes mellitus (DM). The evidence for aspirin use in primary prevention of cardiovascular events in DM is debatable and meta-analyses do not suggest a proven benefit. Despite the lack of evidence, low-dose aspirin therapy has been recommended by many current diabetes guidelines. This article reviews the results of two recently published large randomized clinical trials that have looked at primary prevention of cardiovascular events using aspirin in patients with DM.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk